Wegovy
| Dose / group | Rate |
|---|---|
| Placebo1,261 people | 1% |
| 2.4 mg2,116 people | 3% |
| Dose / group | Rate |
|---|---|
| Placebo303 people | 1% |
| 2.4 mg304 people | 3% |
| 7.2 mg1,311 people | 6% |
Page last checked
Does GLP-1 medication cause hair loss?
Yes. Wegovy and Zepbound both list hair loss in their clinical-trial reaction tables. That does not mean every GLP-1 product has the same findings, or that the medicine explains one person’s hair loss.
What the product trials found
Zepbound
| Dose / group | Rate |
|---|---|
| Placebo958 people | 1% |
| 5 mg630 people | 5% |
| 10 mg948 people | 4% |
| 15 mg941 people | 5% |
Information checked 2026-09-07
How these findings apply
Compound summary coverage
Compounds that list it
0 of 42
Only in a combined category
0
No reaction list in this guide
16
Best available source
FDA label
Which compound summaries list hair loss
These are the reaction entries held in our compound summaries. They do not reproduce every row of each product label. Use the product guides above for the hair-loss findings and their study groups.
◆ Hair loss across 42 compoundsguide or source for every row
| Compound | How it appears | Frequency reported | Source type |
|---|---|---|---|
| TirzepatideZepbound, Mounjaro | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | FDA label |
| SemaglutideWegovy, Ozempic, Rybelsus | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | FDA label |
| LiraglutideVictoza, Saxenda | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | FDA label |
| Retatrutide | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| Cagrilintide | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| Survodutide | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| BPC-157 | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| TesamorelinEgrifta SV, Egrifta WR | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | FDA label |
| PT-141Vyleesi | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | FDA label |
| CJC-1295 | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| Ipamorelin | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| TB-500 | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| GHK-Cu | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| Sermorelin | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| MOTS-c | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| AOD-9604 | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| NAD+ | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| Epitalon | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| Kisspeptin-10 | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| DSIP | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| Hexarelin | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| IGF-1 LR3 | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| PEG-MGF | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| LL-37 | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| KPV | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| Thymosin alpha-1 | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| SS-31Forzinity | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | FDA label |
| Semax | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| Selank | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| Melanotan II | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| Mazdutide | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| Pinealon | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | limited human data |
| AHK-Cu | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| VK2735 | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| Zenagamtide | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| Pemvidutide | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| Brenipatide | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| Eloralintide | Not listed in this summaryThis short reaction list does not include the symptom. Check the full product label or study for more detail. | — | Human trial |
| Enicepatide | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| Macupatide | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| MariTide | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
| Petrelintide | No reaction list in this guideThis guide has no reaction entries. That does not establish that no human safety evidence exists. | — | no human dose shown to work |
What people reported to the FDA
The first table summarizes labels and published trials. This table shows reports filed with the FDA after the medicines went on sale. Each percentage is the share of reports for that product that mention this symptom—not the share of patients who experienced it.
| Product | Share of its own reports | All reports |
|---|---|---|
| Ozempicsemaglutide | below 2.3% of Ozempic reports | 66,161 reports |
| Zepboundtirzepatide | 2.3% of Zepbound reports | 70,141 reports |
| Trulicitydulaglutide | below 2.1% of Trulicity reports | 88,332 reports |
| Rybelsussemaglutide | below 2.1% of Rybelsus reports | 7,379 reports |
| Wegovysemaglutide | below 2.0% of Wegovy reports | 21,044 reports |
| Saxendaliraglutide | below 1.9% of Saxenda reports | 10,040 reports |
| Mounjarotirzepatide | below 1.7% of Mounjaro reports | 93,975 reports |
| Victozaliraglutide | below 1.7% of Victoza reports | 44,086 reports |
3Read deeper
What the labels say about weight change
Zepbound’s label describes hair-loss reactions as associated with weight reduction. That is a finding about the trial groups; it does not identify the cause of shedding in one person.
A reported reaction, its possible cause and its treatment are different questions. The label can document the first without settling the other two.
How long does shedding last?
The reaction tables checked here do not give a recovery timetable. They report how often hair loss was recorded in the study groups.
How long shedding lasts depends on its cause. A clinician can review the timing, recent weight changes, diet, other symptoms and medicines.
What the evidence shows—and what remains unknown
The product labels report hair loss, but there are limits to what those findings explain.
| The claim | What the evidence shows |
|---|---|
| Hair loss was reported during treatment. | Supported for Wegovy and Zepbound. Their own reaction tables include hair loss, with a placebo group for context. |
| The medicine caused my hair loss. | The tables cannot establish a cause for one person. Other changes may need to be considered. |
| All products with the same ingredient have the same rate. | Not supported. Dose, treatment form and study group can differ between products. |
| The table predicts how soon hair will grow back. | Not supported. These reaction tables do not provide a recovery timetable. |
Discuss new hair loss with a clinician
A clinician can review possible causes and whether further checks are needed. Bring the product name and a description of when the shedding began.
Common questions
Is hair loss listed as a side effect of Ozempic or Wegovy?
Wegovy’s label lists hair loss. This finding should not be presented as an Ozempic result: the products have separate labels, doses and study groups.
Check the guide for the product you use. An omitted entry in a compound summary is not a finding that hair loss cannot happen.
Is it the medication or the weight loss?
Zepbound’s label associates the reported hair loss with weight reduction. That does not settle the cause for one person.
A clinician can review the timing and other possible causes.
How long does it last, and does hair grow back?
These reaction tables do not report a recovery timetable. The outlook depends on the cause of the shedding.
Do the different GLP-1 compounds differ on this?
The product labels contain different study groups and doses. Their separate reaction rates do not provide a fair ranking of which medicine causes less hair loss.
Would supplements or a higher protein intake prevent it?
The reaction tables do not test a supplement or protein plan to prevent hair loss. A clinician or dietitian can assess whether nutrition needs attention in your case.
Why do so many pages give a percentage for this?
Some percentages come from real product labels. To interpret one, check the product, dose, study group and placebo result.
A percentage from a weight-management trial should not be presented as a rate for every person taking the same active ingredient.
Is muscle loss a different question from this one?
Yes. A hair-loss entry reports a reaction. Changes in lean mass are body-composition measurements, which require a different kind of evidence.
The full profile for each compound
Want the full picture for one compound? Open its guide for uses, dosage information, side effects and serious warnings.
Every tirzepatide reaction, not only hair loss
The full semaglutide profile behind its hair loss entry
The constipation question, alongside hair loss
The nausea question, alongside hair loss
Look up the medicines mentioned in the hair loss guide
How long hair loss lasts, and why nobody says
From a hair loss page to an exact syringe draw
Reported reactions beyond hair loss
Tirzepatide beyond its hair loss listing
- WEGOVY (semaglutide) injection and tablets — DailyMed SPL, sections 5 and 6.1retrieved 2026-09-13FDA label
- ZEPBOUND (tirzepatide) injection — DailyMed SPL, sections 5 and 6.1retrieved 2026-09-13FDA label